https://biotechmorning.com/news/soon-shiong-pancreatic-cancer-promises Biotech Morning en 2026-06-19T14:28:22.935Z The Billionaire Who Keeps Promising to Cure Pancreatic Cancer https://biotechmorning.com/news/galleri-blood-test-finds-cancer-cant-prove-saves-lives Biotech Morning en 2026-06-19T14:27:22.901Z The Blood Test That Finds Cancer but Can't Prove It Saves Lives https://biotechmorning.com/news/moderna-mrna-flu-vaccine-fda-panel-approval Biotech Morning en 2026-06-19T14:26:28.559Z The Flu Shot Hasn't Changed in 80 Years. That Might Be Over. https://biotechmorning.com/news/personalized-mrna-cancer-vaccine-five-year-melanoma-results Biotech Morning en 2026-06-19T14:25:33.776Z The Cancer Vaccine That Kept Working for Five Years https://biotechmorning.com/news/first-protac-drug-fda-approval-vepdegestrant-2 Biotech Morning en 2026-06-19T14:24:40.555Z The Drug That Destroys Its Target Just Got FDA Approval https://biotechmorning.com/news/merck-keytruda-welireg-adjuvant-kidney-cancer-fda-approval Biotech Morning en 2026-06-19T14:23:51.337Z Merck Just Made Kidney Cancer's Best Drug Even Better https://biotechmorning.com/news/180m-to-fix-the-pill-that-makes-you-sick Biotech Morning en 2026-06-19T14:22:59.749Z $180M to Fix the Pill That Makes You Sick https://biotechmorning.com/news/merck-capvaxive-pediatric-expansion-pfizer-prevnar Biotech Morning en 2026-06-19T14:22:05.103Z Merck Just Found a New Way to Outflank Pfizer's Vaccine Empire https://biotechmorning.com/news/lorlatinib-7-year-pfs-alk-lung-cancer Biotech Morning en 2026-06-19T14:21:15.771Z The Lung Cancer Drug Where Half the Patients Are Still Winning After 7 Years https://biotechmorning.com/news/one-shot-replace-lifetime-cholesterol-pills Biotech Morning en 2026-06-19T14:20:27.805Z One Shot to Replace a Lifetime of Cholesterol Pills https://biotechmorning.com/news/orexin-2-agonist-phase-2-milestone-narcolepsy Biotech Morning en 2026-06-18T14:23:57.867Z The Drug That Wakes Up a Sleeping Giant in Neuroscience https://biotechmorning.com/news/gsk-nuvalent-11-billion-oncology-acquisition Biotech Morning en 2026-06-18T14:23:08.267Z GSK Just Bet $11 Billion That It Can Win Lung Cancer https://biotechmorning.com/news/vc-opposes-us-china-biotech-investment-restrictions Biotech Morning en 2026-06-18T14:22:11.412Z The VC Who Told Washington to Back Off China Biotech https://biotechmorning.com/news/olorofim-antifungal-phase-3-results Biotech Morning en 2026-06-18T14:21:24.742Z The First New Class of Antifungal in 20 Years Just Cleared Its Biggest Hurdle https://biotechmorning.com/news/kardigan-myokardia-crew-400-million-ipo Biotech Morning en 2026-06-18T14:20:31.564Z The MyoKardia Crew Is Back, and Wall Street Just Handed Them $400 Million https://biotechmorning.com/news/beam-therapeutics-base-editing-pku-gene-therapy Biotech Morning en 2026-06-18T14:19:39.348Z One Letter in Your DNA Could Ruin Your Life. Beam Wants to Fix It. https://biotechmorning.com/news/jazz-abcellera-4-billion-tce-deal Biotech Morning en 2026-06-18T14:18:43.861Z Jazz Just Wrote a $4 Billion Check for a Drug That Doesn't Exist Yet https://biotechmorning.com/news/biogen-raythera-billion-dollar-immunology-bet Biotech Morning en 2026-06-18T14:17:41.638Z Biogen Just Dropped $1 Billion on a Company Nobody's Heard Of https://biotechmorning.com/news/lilly-acquires-4e-therapeutics-non-opioid-pain Biotech Morning en 2026-06-18T14:16:50.253Z Lilly's $25 Billion Shopping Spree Just Found a Painkiller That Skips the Opioid Problem https://biotechmorning.com/news/oral-carbapenem-tebipenem-fda-approval-uti Biotech Morning en 2026-06-18T14:15:57.094Z The Antibiotic That Finally Escaped the IV Pole